Metabolix Inc. saw its shares rise after reporting second-quarter results July...million, or 39 cents, a year ago. Also, Johan van Walsem rejoined Metabolix, after a 16-month absence, to assume responsibility for developing... (Page G6, 76 words)Date: Aug 9, 2009

...rose 15 cents to $6.72 in Nasdaq Stock Market trading. (Bloomberg News) Cambridge's Metabolix names chief executive Biotechnology company Metabolix Inc. of Cambridge named Richard P. Eno chief executive, effective March 17. Eno replaces... (Page C2, 703 words)Date: Feb 26, 2008

...market's newest entrant is Mirel, from Cambridge-based Metabolix Inc. It more easily biodegrades than rival materials and...Target Corp. began using it in gift cards at 129 stores. Metabolix is talking with potential clients about dozens more applications... (Page D7, 333 words)Date: Oct 22, 2007

Resignation: Cambridge-based bioscience company Metabolix Inc. said Thomas Auchincloss Jr. will resign as chief financial officer, vice president of finance and corporate development... (Page C2, 315 words)Date: Jul 31, 2007

...agreement between UMass-Lowell and the biotechnology company Metabolix Inc. of Cambridge. McCarthy said it took "many failed attempts...a percentage of the company's profits from the product. Metabolix recently entered into a joint venture with Archer Daniels... (Page T12, 285 words)Date: Jun 21, 2007

...addition to Acme and Double-Take, two other newly public companies have experienced double-digit stock growth. Shares of Metabolix Inc. of Cambridge increased 18.8 percent as of March 30, while shares of Oxford's IPG Photonics Corp. rose 18.4 percent... (Page A50, 649 words)By: Robert Weisman|Date: May 22, 2007

...Palomar Medical Technologies PMTI $754 $41.50 1.2% 23 23 Alnylam Pharmaceuticals ALNY $713 $19.27 -3.5% 24 25 Metabolix MBLX $562 $26.67 -1.2% 25 -- Indevus Pharmaceuticals IDEV $557 $7.54 4.3% The Boston Globe/Bloomberg Massachusetts... (Page E2, 293 words)Date: May 7, 2007

New leader: Metabolix Inc., a Cambridge developer of biodegradable plastics from corn sugar, said chairman Jay Kouba will replace James J. Barber... (Page C2, 370 words)Date: May 4, 2007

...22 Alnylam Pharmaceuticals ALNY $739 $19.96 0.8% 24 24 Momenta Pharmaceuticals MNTA $582 $16.02 -0.5% 25 -- Metabolix MBLX $569 $26.99 50.0% The Boston Globe/Bloomberg Massachusetts Technology and Life Sciences indexes are price... (Page D2, 290 words)Date: Apr 30, 2007

...businesses." At today's hearing, officials from alternative energy start-ups, including Jim Barber , chief executive of Metabolix Inc. in Cambridge, will talk about technologies in their labs that could help reduce carbon emissions. "There are a lot... (Page D1, 563 words)By: Robert Weisman|Date: Mar 8, 2007